24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Ichilov Medical Center
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
19:09
"Without Mellanox, Nvidia wouldn’t have become a $4 trillion powerhouse"
18:59
Crusoe acquires Israeli startup Atero in $150 million deal
11:01
Pool-cleaning robot maker Maytronics is looking to resurface following a deep dive in value
10:17
FIMI to invest $80 million in Benny Landa's collapsed digital printing company
More stories
Buzz
Most popular
Daily
Weekly
1
Crusoe acquires Israeli startup Atero in $150 million deal
2
Seemplicity raises $50 million to automate exposure management with AI
3
The 83-year-old who sold his invention for $466 million, and still walks to work every morning
4
Inside Nir Zuk’s departure and Palo Alto’s next gamble
5
Palo Alto Networks founder Nir Zuk steps down, marking end of an era in cybersecurity
More news
Ichilov Medical Center
2 stories about Ichilov Medical Center
"The genome project will change the face of medicine in Israel and save human lives"
10.11.24
|
Roni Dori
Psifas is an ambitious new genome project aiming to create a genetic database of Israel’s citizens, with a budget of NIS 250 million. The collected information already provides information that will make it possible to treat life-threatening diseases in the subjects. The hope is that after accumulating 100,000 samples, the database will help jumpstart the biotech industry. CEO Prof. Gabi Barbash: "Psifas is a great achievement and advantage for Israel, which aspires to become a global hub of biotechnological information."
BioLight to partner with Ichilov Medical Center to develop innovative ophthalmology technologies
29.11.21
|
CTech
According to the terms of the agreement, the company will retain the primary right to license technologies developed at Ichilov